Benitec Biopharma Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $180.0M | $97.7M | $50.9M | $2.5M | $4.1M | $19.8M | $9.8M | $15.7M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $181.7M | $98.5M | $51.7M | $3.7M | $4.8M | $20.6M | $10.8M | $18.8M |
| Property, Plant & Equipment | $178.0K | $131.0K | $179.0K | $87.0K | $222.0K | $375.0K | $374.0K | $470.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $182.6M | $99.6M | $52.2M | $4.5M | $6.0M | $21.4M | $11.6M | $19.2M |
| Liabilities | ||||||||
| Accounts Payable | $913.0K | $201.0K | $1.4M | $1.1M | $422.0K | $274.0K | $282.0K | $1.5M |
| Total Current Liabilities | $5.3M | $1.8M | $4.9M | $4.0M | $2.5M | $1.4M | $1.1M | $2.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $5.6M | $2.3M | $5.0M | $4.3M | $3.1M | $1.4M | $1.3M | $2.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-273.7M | $-228.2M | $-190.3M | $-181.3M | $-148.3M | $-130.1M | $-116.6M | $-108.9M |
| Total Stockholders' Equity | $177.0M | $97.3M | $47.2M | $202.0K | $2.9M | $20.0M | $10.2M | $16.6M |